Questionnaire survey on the Japanese guidelines for treatment of hypertension in the elderly: 1999 revised version

被引:8
作者
Ogihara, T
Morimoto, S
Okaishi, K
Hiwada, K
Matsuoka, H
Matsumoto, M
Takishita, S
Shimamoto, K
Shimada, K
Abe, I
Kohara, K
Ouchi, Y
机构
[1] Osaka Univ, Sch Med, Dept Geriatr Med, Suita, Osaka 5650871, Japan
[2] Ehime Univ, Sch Med, Dept Internal Med 2, Matsuyama, Ehime 790, Japan
[3] Dokkyo Univ, Sch Med, Dept Hypertens & Cardiorenal Med, Mibu, Tochigi 32102, Japan
[4] Kanazawa Med Univ, Dept Gerontol, Kanazawa, Ishikawa, Japan
[5] Univ Ryukyus, Sch Med, Dept Internal Med 3, Okinawa, Japan
[6] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan
[7] Jichi Med Sch, Dept Cardiol, Minami Kawachi, Tochigi 32904, Japan
[8] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan
[9] Ehime Univ, Sch Med, Dept Geriatr Med, Matsuyama, Ehime 790, Japan
[10] Univ Tokyo, Dept Geriatr Med, Tokyo, Japan
关键词
hypertension; guidelines in the elderly; questionnaire survey;
D O I
10.1291/hypres.25.69
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
A questionnaire survey was administered to Japanese clinical specialists in hypertension in order to gauge their opinions on the 1999 revised version of the Guidelines for Hypertension in the Elderly prepared by the Comprehensive Research Project on Aging and Health of the Ministry of Health and Welfare. Out of 162 council members of the Japanese Society of Hypertension, 122 (75%) replied. The majority (93%) of respondents approved of the guidelines in general, and 72% of them approved of the age-related setting of a therapeutic goal for blood pressure. Sixty-five percent of respondents selected long-acting Ca antagonists, ACE inhibitors and low-dose diuretics as first-line agents for hypertension without complications in the elderly. The results of the questionnaire survey should be reflected in the next version of the guidelines.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 1991, JAMA, V265, P3255
[2]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[3]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[4]   MORBIDITY AND MORTALITY IN THE SWEDISH TRIAL IN OLD PATIENTS WITH HYPERTENSION (STOP-HYPERTENSION) [J].
DAHLOF, B ;
LINDHOLM, LH ;
HANSSON, L ;
SCHERSTEN, B ;
EKBOM, T ;
WESTER, PO .
LANCET, 1991, 338 (8778) :1281-1285
[5]  
Fujishima M, 2001, HYPERTENS RES, V24, P613
[6]  
Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967
[7]   Shanghai trial of nifedipine in the elderly (STONE) [J].
Gong, LS ;
Zhang, WZ ;
Zhu, YJ ;
Zhu, JR ;
Kong, DW ;
Page, V ;
Ghadirian, P ;
LeLorier, J ;
Hamet, P .
JOURNAL OF HYPERTENSION, 1996, 14 (10) :1237-1245
[8]   Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].
Hansson, L ;
Lindholm, LH ;
Niskanen, L ;
Lanke, J ;
Hedner, T ;
Niklason, A ;
Luomanmäki, K ;
Dahlöf, B ;
de Faire, U ;
Mörlin, C ;
Karlberg, BE ;
Wester, PO ;
Björck, JE .
LANCET, 1999, 353 (9153) :611-616
[9]   Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study [J].
Hansson, L ;
Lindholm, LH ;
Ekbom, T ;
Dahlöf, B ;
Lanke, J ;
Scherstén, B ;
Wester, PO ;
Hedner, T ;
de Faire, U .
LANCET, 1999, 354 (9192) :1751-1756
[10]   Guidelines for hypertension in the elderly - 1999 revised version [J].
Hiwada, K ;
Ogihara, T ;
Matsumoto, M ;
Matsuoka, H ;
Takishita, S ;
Shimamoto, K ;
Toba, K ;
Abe, I ;
Kohara, K ;
Morimoto, S ;
Mikami, H ;
Iwai, K ;
Takasaki, M ;
Kawano, Y ;
Higashiura, K ;
Kozaki, K ;
Eto, M ;
Fujishima, M .
HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 22 (04) :231-259